devicelink.com: News Trends - Devices Represented on Inc.'s List of Fastest-Growing Companies   HemCon Medical Technologies (Portland, OR), which makes bandages that control bleeding and infection for the healthcare industry, the Department of Defense, and first responders worldwide.

pharmaceutical-business-review.com: HemCon Medical completes fungal nail infection study   HemCon Medical Technologies has completed two independent studies on its topical treatment of onychomycosis, a common fungal nail infection.

medicalnewstoday.com: HemCon Medical Technologies, Inc. Announces Promising Results From Nail Anti-Fungal Study   HemCon Medical Technologies today announced the completion of two independent studies on its topical treatment of Onychomycosis, a common fungal nail infection.  The studies were conducted with a formulation based on HemCon's newest proprietary platform technology that provides a controlled release broad spectrum antifungal and antibacterial agent to fight infection.

HemCon Medical Technologies Announces New President and CFO  Portland, Ore. -September 4, 2008 - HemCon Medical Technologies, Inc., a leading global medical products company focused on advanced wound care innovations, today announced two new additions to its executive team: William "Bill" Block has been promoted to president, US and Nick Hart has been named chief financial officer.

HemCon Medical Technologies, Inc. Announces Promising Results from Nail Anti-Fungal Study
Wound Care Innovator Enters Robust Fungal Care Market - Portland, Ore. October 14, 2008 - HemCon Medical Technologies today announced the completion of two independent studies on its topical treatment of Onychomycosis, a common fungal nail infection.  The studies were conducted with a formulation based on HemCon's newest propietary platform technology that provides a controlled release broad spectrum antifungal and antibacterial agent to fight infection.

HemCon Medical Technologies Ranked in Inc. 500
Medical Device Company Recognized As One of America's Fastest-Growing Private Companies
Portland, Ore. - Sept. 4, 2008 - HemCon Medical Technologies, Inc., a leading provider of hemostatic bandages, today announced its rank as 459 on Inc. magazines's 27th annual list of America's 500 fastest-growing private companies.

HemCon Medical Technologies, Inc. and Institute of Technology, Sligo Join Forces to Develop New Antibacterial Technology   Portland, Ore. and Sligo, Ireland - Aug. 28 2008 - HemCon Medical Technologies today announced an agreement with IT Sligo (Institute of Technology Sligo, Ireland) to license the exclusive global rights to research, develop, manufacture and market a controlled release hydrogen peroxide technology that provides broad spectrum antibacterial and antiseptic properties.

tahilla.typepad.com: MRSA Watch - Better Bandages Batter Bugs   
HemCon's bandages, created from a natural substance in shrimp shells called chitosan, stop bleeding - including extensive arterial bleeding - within two to five minutes.  The antibacterial barrier properties of the bandages help prevent infection transmission to other patients and health care providers and also make it easier for medical professionals to help prevent infections at incision site wounds.
 
HemCon Bandages Receive Expanded Indications for Antibacterial Barrier, Including MRSA
Hemostatic Dressing's Antibacterial Barrier Reduces Risk of Hospital-Acquired Infections
Portland, Ore. - August 11, 2008 - The Centers for Disease Control and Prevention (CDC) estimates that 1.7 million hospital patients acquire infections each year, and 103,000 die as a result.  HemCon Medical Technologies, Inc., a global medical products company focused on advanced wound care innovations, today announced new antibacterial indications by the FDA, including a barrier against MRSA, for its HemCon® Bandages, ChitoFlex® dressings and KytoStat® Bandages.